s 11568 has been researched along with bay-k-8644 in 2 studies
| Studies (s 11568) | Trials (s 11568) | Recent Studies (post-2010) (s 11568) | Studies (bay-k-8644) | Trials (bay-k-8644) | Recent Studies (post-2010) (bay-k-8644) |
|---|---|---|---|---|---|
| 16 | 0 | 0 | 2,555 | 0 | 144 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giesen-Crouse, E; Morain, P; Peglion, JL | 1 |
| Abraham, C; Aptel, H; Lombet, A; Nagel, N; Peglion, JL; Randle, JC; Renaud, JF | 1 |
2 other study(ies) available for s 11568 and bay-k-8644
| Article | Year |
|---|---|
Ca2+ channel inhibition in a rat osteoblast-like cell line, UMR 106, by a new dihydropyridine derivative, S11568.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Barium; Calcium Channel Blockers; Cell Line; Dihydropyridines; Electrophysiology; Osteoblasts; Rats | 1992 |
Ca2+ channel inhibition by a new dihydropyridine derivative, S11568, and its enantiomers S12967 and S12968.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding, Competitive; Calcium Channel Blockers; Calcium Radioisotopes; Cell Line; Dihydropyridines; Electrophysiology; Guinea Pigs; Heart; In Vitro Techniques; Inosine Triphosphate; Isradipine; Male; Muscle, Smooth, Vascular; Myocardium; Oxadiazoles; Rats; Ryanodine; Stereoisomerism | 1990 |